Background
==========

Chronic periodontitis (CP) is an infectious disease caused by microorganisms, which can lead to progressive destruction of the periodontal tissues and early tooth loss \[[@b1-medscimonit-24-7090]\]. The typical clinical symptoms are attachment loss, formation of periodontal pockets, and bone absorption. Bacteria and their metabolites on plaque are an initial factor in the pathogenesis \[[@b2-medscimonit-24-7090]\]. With a rough and poly-porous surface, dental calculus provides superior conditions for bacteria to colonize, proliferate, and cause disease \[[@b3-medscimonit-24-7090]\]; thus, the primary objective of initial periodontal treatment is to eliminate bacteria and calculus on the root surface and maintain a biologically harmonious root surface \[[@b4-medscimonit-24-7090],[@b5-medscimonit-24-7090]\].

Scaling and root planing (SRP), performed by hand or with ultrasonic devices, is a basic and essential procedure for CP treatment in first-stage periodontal therapy. Considerable evidence supports the view that hand-held instruments and ultrasonic devices have similar clinical effectiveness \[[@b6-medscimonit-24-7090],[@b7-medscimonit-24-7090]\]. Both approaches have advantages and disadvantages. Hand-held instruments provide a better sense of touch for dentists to determine if the root surface is rough, but they require more time, physical effort, and special professional training. In comparison, ultrasonic devices have advantages of efficiency and less operator fatigue, but they have the risks of damaging the root surfaces, leaving aerosol contamination and generating vibrations that may lead to dental fear and discomfort \[[@b8-medscimonit-24-7090]\]. Hand-held instruments and ultrasonic devices both have difficulties in accessing the anatomical variations, such as root concavities, root furcations, grooves, and the distal surfaces of molars \[[@b9-medscimonit-24-7090]\].

Various types of lasers have been applied in periodontal treatments. Among all laser therapies, the use of Er: YAG lasers (ERLs) is most suitable for periodontal treatment \[[@b10-medscimonit-24-7090], [@b11-medscimonit-24-7090]\] because it is capable of achieving both soft- and hard-tissue ablation \[[@b12-medscimonit-24-7090]\]. While Nd: YAG lasers, CO2 lasers, and diode lasers are suitable for removing soft tissue \[[@b12-medscimonit-24-7090]\], if they are used for hard tissue removal, thermal adverse effects can lead to cracks on the root surfaces \[[@b13-medscimonit-24-7090]--[@b15-medscimonit-24-7090]\]. ERLs have an ideal wavelength of 2.94 um, which is close to the maximum absorption coefficient of water and hydroxyapatite. When ERLs are used to irradiating, the absorption of the energy by water and hydrous organic components rapidly builds up the evaporation of water, resulting in internal pressure and microexplosions in the calculus \[[@b16-medscimonit-24-7090]\]. ERLs can be applied to remove subgingival calculus that traditional mechanical hand instruments cannot reach and to eliminate smear layers of infected cementum without thermal adverse effects \[[@b17-medscimonit-24-7090]--[@b19-medscimonit-24-7090]\]. Furthermore, ERLs possess bactericidal and endotoxic effects \[[@b20-medscimonit-24-7090]--[@b22-medscimonit-24-7090]\] and have the potential to accelerate cell proliferation and reattachment to the root surfaces \[[@b23-medscimonit-24-7090]--[@b26-medscimonit-24-7090]\]. Er,Cr: YSGG lasers are also applied in periodontal treatment as an adjunct to non-surgical periodontal treatment \[[@b27-medscimonit-24-7090],[@b28-medscimonit-24-7090]\]. However, its wavelength is different from that of ERLs, so the present meta-analysis focusing on ERLs aimed to provide a precise systematic evaluation of the effectiveness of ERLs as an adjunct to SRP to guide clinical use in periodontal treatment.

Material and Methods
====================

This meta-analysis was designed in advance, and followed the guidelines of the QUOROM statement \[[@b29-medscimonit-24-7090]\] and the PRISMA statement \[[@b30-medscimonit-24-7090]\].

PICOS question
--------------

A clinical questionnaire \[[@b31-medscimonit-24-7090]\] was established by the participants, intervention, comparison, outcomes, and study design (PICOS) in this meta-analysis.

1.  **P**: Chronic periodontal patients who needed non-surgical treatment.

2.  **I**: ERLs as an adjunctive therapy to SRP.

3.  **C**: SRP conducted with manual curettes and/or ultrasonic devices.

4.  **O**: Clinical effectiveness and patients' perceptions.

5.  **S**: Randomized controlled trials (RCTs).

Search strategy
---------------

The following important biomedical electronic databases were searched for relevant publications until January 31, 2018: PubMed, the Cochrane Controlled Clinical Trial Register (CCCTR), Medline, EMBase, Science Direct, OVID, ISI Web of Knowledge, China National Knowledge Internet (CNKI), and the Chinese BioMedical Literature Database (CBM).

Search strategies were permuted and combined by medical subheadings (MeSH) and keywords as the following phrases:

("Periodontitis" \[MeSH\] OR "Chronic Periodontitis" \[MeSH\] OR "Periodontal Diseases" \[MeSH\]) AND ("Lasers, Solid-State" \[MeSH\] OR "Erbium" \[MeSH\] OR "Lasers" \[MeSH\] OR "Laser Therapy" \[MeSH\] OR "erbium yttrium aluminum garnet") AND ("periodontal non-surgical treatment" OR "periodontal non-surgical therapy" OR "scaling root planing" OR "dental scaling" OR "periodontal treatment" OR "periodontal therapy" OR "Dental Scaling"\[MeSH\] OR "Root Planing" \[MeSH\]) AND ("periodontal pocket\*" OR "pocket depth" OR "plaque index" OR "dental plaque" OR "dental calculus" OR "attachment loss" OR "clinical attachment level" OR "Periodontal Pocket"\[MeSH\] OR "Periodontal Attachment Loss"\[MeSH\]).

search strategy in PubMed was
-----------------------------

1.  \#1 "Lasers, Solid-State" \[MeSH\] OR "Erbium" \[MeSH\] OR "Lasers" \[MeSH\].

2.  \#2 "scaling root planing" OR "Dental Scaling" \[MeSH\] OR "Root Planing" \[MeSH\].

3.  \#3 "Periodontitis" \[MeSH\] OR "Chronic Periodontitis" \[MeSH\].

4.  \#4 randomized controlled trials.

5.  \#5 \#1AND\#2AND\#3AND\#4.

Furthermore, the references of selected full-text articles and related reviews were scrutinized to obtain potentially relevant studies. Only published articles in Chinese and English languages were included. No restriction was applied concerning the publication year.

All searched articles from different databases were entered into NoteExpress. Sifting was performed independently by 2 researchers to minimize the potential bias among researchers. Preliminary selection was achieved by screening titles and abstracts and secondary selection was conducted by screening full-text articles. Disagreements on the inclusion or exclusion of the retrieved papers were resolved by discussion.

Inclusion criteria
------------------

1.  A1: Randomized clinical trials

2.  A2: General CP patients who needed non-surgical periodontal treatment

3.  A3: ERLs adjunctive to traditional SRP by hand or/and ultrasonic devices compared with SRP alone

4.  A4: Clinical parameters

Exclusion criteria
------------------

1.  B1: Studies not designed as a randomized clinical trial

2.  B2: Patients who were aged ≤15 years old, who had other types of periodontitis, who had systematic diseases, who took antibiotics or medications that could alter the investigated clinical effect, who received periodontal therapy in the past 6 months, or who were pregnant

3.  B3: Surgical therapy or maintenance therapy

4.  B4: The WMD value of the curative effect indicator data and the 95%CI data cannot be extracted, converted or used

Study characteristics
---------------------

The following information was collected for each included publication: study design, number of patients, the devices used in the test and control groups, and clinical effectiveness with the follow-up period. Discrepancies were solved by discussions. Data were independently extracted from included full-text publications by 2 researchers.

Quality assessment
------------------

A methodological quality evaluation of all included RCTs was conducted independently by 2 researchers using the Jadad score scale \[[@b32-medscimonit-24-7090]\]. The evaluation standard consisted of random sequence generation, randomized concealment, blinding, and loss to follow-up. The first 3 standards were scored as appropriate (2 scores), unclear (1 score), or inappropriate (0 score) and the fourth standard was scored described (1 score) or no (0 score). Total scores ranging from 1 to 4 were rated as low quality, and total scores ranging from 5 to 7 were rated as high quality.

Statistical analysis
--------------------

Heterogeneity was evaluated by a *Q* test. Significant heterogeneity was indicated by *p*\<0.1. A random-effects model was selected to calculate the weighted mean differences (WMDs) and their 95%CIs when heterogeneity was high (*p*\<0.1); otherwise, a fixed-effects model was applied \[[@b33-medscimonit-24-7090]\]. For WMD, *p*\<0.01 was considered statistically significant.

Sensitivity analysis was conducted by switching effect models. The presence of publication bias was investigated for each outcome of interest by Begg's test for quantitative analysis \[[@b34-medscimonit-24-7090]\]. Publication bias existed at *p* value\<0.1. All statistical analyses were conducted using Stata 11 Intercooled (Stata Corporation, College Station, TX, USA).

Results
=======

Search results
--------------

As shown in [Figure 1](#f1-medscimonit-24-7090){ref-type="fig"}, there were 367 related studies, from which 110 duplicate articles were identified and deleted. Based on viewing of titles and abstracts, 223 papers were excluded; after screening the full text, 22 articles were excluded. Finally, 12 articles (10 RCTs) entered the quality assessment and data extraction stage. The characteristics of the eligible studies are shown in [Table 1](#t1-medscimonit-24-7090){ref-type="table"}. A total of 307 patients participated, and 301 patients finished the 10 pooled studies.

Risk of bias within studies
---------------------------

Analysis of the methodological quality of the included RCTs revealed that 6 studies had a low risk of bias \[[@b38-medscimonit-24-7090],[@b40-medscimonit-24-7090]--[@b46-medscimonit-24-7090]\] and the other 4 were at high risk of bias \[[@b35-medscimonit-24-7090]--[@b37-medscimonit-24-7090],[@b39-medscimonit-24-7090]\]. The results of the Jadad scale quality analysis are presented in [Table 2](#t2-medscimonit-24-7090){ref-type="table"}.

### Meta-analysis results

The outcomes of interest were changes in probing depth (PD), clinical attachment level (CAL) measured separately from baseline to 3-, 6-, and 12-month follow-ups, and visual analog scale (VAS) scores immediately after treatment.

PD reduction
------------

A significant difference in PD reduction in favor of ERLs+SRP compared to SRP was observed at the 3-month follow-up, as shown in [Figure 2](#f2-medscimonit-24-7090){ref-type="fig"} (WMD=0.33, 95%CI range 0.25 to 0.41, *p\<*0.001), with heterogeneity (χ^2^=19.83,*p*=0.003, I^2^=69.7%). As high heterogeneity was detected, the study by Li Fengzhou \[[@b36-medscimonit-24-7090]\] was excluded because its methodological quality was low. The heterogeneity was substantially decreased (χ^2^=5.27, *p*=0.39, I^2^=5.1%), and the result was consistent (WMD=0.27, 95%CI range 0.18 to 0.36, *p*\<0.001).

No significant difference in PD reduction was observed in favor of ERLs+SRP compared to SRP at the 6-month follow-up, as shown in [Figure 3](#f3-medscimonit-24-7090){ref-type="fig"} (WMD=0.12, 95%CI range −0.07 to 0.31, *p*=0.21) without heterogeneity (χ^2^=1.00, *p*=0.80, I^2^=0%); the data for the 12-month follow-up are shown in [Figure 4](#f4-medscimonit-24-7090){ref-type="fig"} (WMD=0.14, 95%CI range −0.10 to 0.37, *p*=0.25), with no heterogeneity (χ^2^=0.41, *p*=0.52, I^2^=0%).

CAL gain
--------

Significant differences in the 3-month outcomes were observed (WMD=0.35, 95%CI range 0.31 to 0.39, *p*\<0.001), with low heterogeneity (χ^2^=8.42, *p*=0.209, I^2^=28.8%). Forest plots for the CAL gain at the 3-month follow-up are shown in [Figure 5](#f5-medscimonit-24-7090){ref-type="fig"}.

No significant difference in CAL gain was observed between ERLs+SRP and SRP, as shown in [Figure 6](#f6-medscimonit-24-7090){ref-type="fig"}, at the 6-month follow-up (WMD=−0.01, 95%CI range −0.21 to 0.19, *p*=0.92) without heterogeneity (χ^2^=2.81, *p*=0.422, I^2^=0%); the 12-month follow-up is shown in [Figure 7](#f7-medscimonit-24-7090){ref-type="fig"} (WMD=0.09, 95%CI range −0.17 to 0.36, *p*=0.49) without heterogeneity (χ^2^=0.72, *p*=0.397, I^2^=0%).

VAS
---

A significant difference was observed in favor of ERLs+SRP compared to SRP (WMD=−1.63, 95%CI range −2.05 to −0.21, *p*\<0.001) with moderate heterogeneity (χ^2^=1.78, *p*=0.182, I^2^=44%). Forest plots for VAS are shown in [Figure 8](#f8-medscimonit-24-7090){ref-type="fig"}.

### Sensitivity analysis

Sensitivity analysis was conducted by switching the effect model for all investigated parameters at all follow-up periods. All results remained consistent, indicating that the results were stable.

### Publication bias

Publication bias was investigated by Begg's test for quantitative analysis, in terms of PD reduction, *p*=1.000; and in terms of the CAL gain *p*=0.23. All *p* values were greater than 0.1 and indicated the absence of publication bias.

Discussion
==========

Superior to the previous study
------------------------------

This meta-analysis systematically evaluated available clinical evidence concerning ERLs as an adjunct to SRP, published up to January 2018, with 307 pooled patients from 10 RCTs, and quantitatively assessed 3 clinical parameters that were evaluated separately according to follow-up period. Additionally, sensitivity analysis was performed and publication bias was assessed. These advantages increase the reliability and stability of the results over those of the previous study \[[@b47-medscimonit-24-7090]\]; thus, this meta-analysis is the most comprehensive evaluation to date of the clinical effectiveness of ERLs+SRP.

Summary of the main findings
----------------------------

The notable findings of this meta-analysis indicated that significant differences were observed at the short-term (3-month) follow-up in favor of ERLs+SRP in terms of PD reduction and CAL gain, with moderate or low heterogeneity, respectively. The main source of heterogeneity appears to originate from the study by Li Fengzhou \[[@b36-medscimonit-24-7090]\], for which the methodological quality was low. After excluding that study, the heterogeneity substantially decreased, and the results remained consistent. The medium-term and long-term follow-up of clinical parameters of PD and CAL changes showed no differences. These results could be interpreted partially as showing that ERLs can remove smear layers, can accelerate periodontal ligament fibroblasts and blood cell adherence to the root surface, and can eliminate endotoxins and bacteria \[[@b48-medscimonit-24-7090]\]. Although the medium- and long-term clinical effects were closely related to initial treatment, treatment effectiveness diminished over time and was affected by confounding factors such as the frequency of maintenance care, dietary habits, the patients' oral hygiene habits, systemic disorders, and the host immune response \[[@b49-medscimonit-24-7090]\].

In terms of patients' perceptions during treatment, ERLs+SRP had an advantage over SRP as measured by VA,S with moderate heterogeneity. This result was in accordance with a clinical trial that applied 2 methods to measure patients' pain perceptions during supportive care \[[@b50-medscimonit-24-7090]\]. ERLs were characterized by no vibration and little sound, patients may perceive less fear and nervousness, and thus experience less pain. In addition, the mechanism may have potential relevance because ERLs were capable of melting exposed fresh dentinal tubules and cementum caused by SRP \[[@b51-medscimonit-24-7090]\].

The parameters investigated in this meta-analysis are crucial for periodontal treatment. PD and CAL are the most frequently used and the most informative parameters for estimating the severity of inflammation as well as the response to treatment during periodontal therapy \[[@b52-medscimonit-24-7090]\]. The VAS is used to measure patients' perception of pain. Pain experienced during treatment should be discussed, not only due to the treatment itself, but also due to dental fear caused by pain, which may result in missing appointments and affect the effectiveness of periodontal treatment \[[@b49-medscimonit-24-7090]\].

Quality of evidence
-------------------

The studies included in this meta-analysis were low in methodological quality, presuming a limitation in methodology. The most frequently unsatisfied methodological criterion was the absence of allocation concealment, as only 2 studies used the correct method. In 8 RCTs, blinding methods were adapted for outcome examiners (but not for patients and doctors) for the differences in devices and procedures between the test and control groups, and the blinding methods of other studies were unclear. Five of the 10 RCTs \[[@b37-medscimonit-24-7090],[@b39-medscimonit-24-7090],[@b43-medscimonit-24-7090]--[@b46-medscimonit-24-7090]\] used the correct parallel randomization, while 5 of the 10 RCTs \[[@b35-medscimonit-24-7090],[@b36-medscimonit-24-7090],[@b38-medscimonit-24-7090],[@b40-medscimonit-24-7090]--[@b42-medscimonit-24-7090]\] used a split-mouths design, which has the potential disadvantage of within-patient bias for carry-across effects \[[@b53-medscimonit-24-7090]\].

The heterogeneity could be caused by differences among the included studies, such as different inclusion criteria for CP patients, the combined use of calculus detection systems, ERLs parameter settings, the inclusion of smokers, and study design method.

Sensitivity analysis was conducted, and consistent results were achieved. Analysis of publication bias was performed. The trim-and-fill analysis assumed no missing studies. Begg's test revealed no publication bias. Therefore, the possibility of publication bias can be excluded.

Limitations
-----------

### Limitation of the evidence

Lasers, unlike other instruments, have no defined and accepted protocols for standard usage in periodontal treatment \[[@b54-medscimonit-24-7090]--[@b56-medscimonit-24-7090]\], and the studies included in this meta-analysis used different power parameter settings. There were also different inclusion criteria for long-term periodontal patients among the included studies. Smoking is a risk factor for CP \[[@b57-medscimonit-24-7090]\]; 2 RCTs \[[@b42-medscimonit-24-7090],[@b45-medscimonit-24-7090],[@b46-medscimonit-24-7090]\] involved both smokers and non-smokers, and although an intergroup balance was achieved at baseline, the outcomes affected by this confounding factor were unknown. Some of the included studies were small in terms of sample size, which may have led to a problem with low statistical power. Some included studies tested different numbers of sites on different numbers of teeth, with different tooth positions. These confounding factors discussed above may have increased the interstudy heterogeneity. Evidence focused on long-term clinical outcomes is still lacking. The expense of lasers is a main barrier to broader use, but no evidence has addressed their cost-effectiveness. Adverse events were evaluated in only 1 study, by Rotundo \[[@b42-medscimonit-24-7090]\]. Two periodontal abscesses were observed in the ERLs+SRP group, while no periodontal abscesses were found in the SRP group. There was no additional discussion about this issue.

Limitation of the meta-analysis
-------------------------------

Articles published only in English and Chinese were selected for this systematic review. These choices might have led to bias in the results of important studies published in languages other than English and Chinese.

Implications for clinical practice
----------------------------------

The results of this meta-analysis suggest that ERLs as an adjunct to SRP could provide better short-term clinical effectiveness than SRP alone. However, these benefits were not stable after a long follow-up period. Therefore, dentists should comprehensively balance the cost and benefits for patients and the convenience the clinicians may experience. Although the benefit achieved was not outstanding, patients with moderate or advanced periodontal disease would benefit from this improvement, because it takes long-term repeated supportive periodontal care, and this benefit might be superimposed. Based on the hemostasis characteristics of ERLs \[[@b12-medscimonit-24-7090]\], patients with hypertensive diseases and hemagglutination inhibition, such as hematological disorders, diabetes, and hepatic disease, would likely benefit from this new instrument.

Implications for research
-------------------------

As discussed above, the following recommendations have been made. First, parallel-arm controlled, large sample-size, long-term clinical trials are needed in future studies, and clinical trials should be of high methodological quality, like the CONSORT statement \[[@b58-medscimonit-24-7090]\]. Second, to achieve the best efficacy and safety, studies on clinical practice protocols for achieving safe use, such as power settings, pulse durations, and repetition rates, are needed. Third, evidence is needed to address the choice for patients and doctors concerning cost-effect analysis, and patients' perceptions of pain, as well as doctor training and ability to operate the lasers.

Conclusions
===========

ERLs as an adjunct to SRP may have additional benefits in the short-term, as patients experience less pain compared to SRP. There were no significant differences in clinical effectiveness at the medium- and long-term follow-ups. Long-term, well-designed RCTs are required in the future.
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###### 

Characteristic of included studies.

  Study                                                                    Design                 Patients          Test group                 Control group                Outcomes
  ------------------------------------------------------------------------ ---------------------- ----------------- -------------------------- ---------------------------- ----------------------------
  Ming \[[@b35-medscimonit-24-7090]\]                                      Split mouth            18 patients       Ultrasonic+ ERLs           Ultrasonic                   6 months PD, CAL
  Fengzhou \[[@b36-medscimonit-24-7090]\]                                  Split mouth            30 patients       Ultrasonic+ Manual+ ERLs   Ultrasonic+ manual           1, 3 months PD
  Weiyan \[[@b37-medscimonit-24-7090]\]                                    Parallel arm           82 patients       Manual+ Ultrasonic+ ERLs   Manual+ ultrasonic devices   VAS
  Kaiyue \[[@b38-medscimonit-24-7090]\]                                    Split mouth            11 patients       Manual+ Ultrasonic+ ERLs   Ultrasonic+ manual           3 months PD, CAL
  Shuxia \[[@b39-medscimonit-24-7090]\]                                    Parallel arm           40 patients       Ultrasonic+ ERLs           Ultrasonic                   1.5, 3 months CAL
  Lopes \[[@b40-medscimonit-24-7090],[@b41-medscimonit-24-7090]\]          Split mouth quadrant   21--19 patients   Manual+ ERLs               Manual                       1, 3, 6, 12 months PD, CAL
  Rotundo \[[@b42-medscimonit-24-7090]\]                                   Split mouth quadrant   27-26patients     Manual+ Ultrasonic+ ERLs   Ultrasonic+ manual           3, 6 months PD, CAL, VAS
  Yilmaz \[[@b43-medscimonit-24-7090]\]                                    Parallel arm           18 patients       SRP+ ERLs                  SRP                          3 months PD, CAL
  Yilmaz \[[@b44-medscimonit-24-7090]\]                                    Parallel arm           20 patients       SRP+ ERLs                  SRP                          3 months PD, CAL
  Sanz-Sánchez \[[@b45-medscimonit-24-7090],[@b46-medscimonit-24-7090]\]   Parallel arm           40--37 patients   Ultrasonic+ ERLs           Ultrasonic                   3, 6, 12 months PD, CAL

###### 

Quality assessment of studies.

  Study                                                                                   Random generation     Allocation concealment   Blinded method     Lost of follow-up   Score
  --------------------------------------------------------------------------------------- --------------------- ------------------------ ------------------ ------------------- -------
  Ming 2015 \[[@b35-medscimonit-24-7090]\]                                                Random                Unclear                  Unclear            Not mentioned       3
  Fengzhou 2016 \[[@b36-medscimonit-24-7090]\]                                            Toss a coin           Unclear                  Unclear            Not mentioned       4
  LuoWeiyan 2017 \[[@b37-medscimonit-24-7090]\]                                           Random number table   Unclear                  Unclear            Not mentioned       4
  Kaiyue 2017 \[[@b38-medscimonit-24-7090]\]                                              Computer              Unclear                  Examiner blinded   Not mentioned       5
  Shuxia 2017 \[[@b39-medscimonit-24-7090]\]                                              Random                Unclear                  Examiner blinded   Not mentioned       4
  Lopes 2008 \[[@b40-medscimonit-24-7090]\], 2010 \[[@b41-medscimonit-24-7090]\]          Computer              Sealed envelopes         Examiner blinded   Described           7
  Rotundo 2010 \[[@b42-medscimonit-24-7090]\]                                             Computer              Unclear                  Examiner blinded   Described           6
  Yilmaz 2012 \[[@b43-medscimonit-24-7090]\]                                              Computer              Unclear                  Examiner blinded   Not mentioned       5
  Yilmaz 2013 \[[@b44-medscimonit-24-7090]\]                                              Computer              Unclear                  Examiner blinded   Not mentioned       5
  Sanz-Sánchez 2015 \[[@b45-medscimonit-24-7090]\], 2016 \[[@b46-medscimonit-24-7090]\]   Computer              Sealed envelopes         Examiner blinded   Described           7
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